[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$dsnky
$dsnky sees increased social media engagement with a positive outlook from RBC on IDYA. Top posts highlight gains in crypto and cloud names, while $dsnky is mentioned among the losers.
About $dsnky
A social media analysis of the cryptocurrency $dsnky.
Insights #
- $dsnky engagements is up XXXXXX% from the previous week.
Engagements: XXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXX +614%
1 Month: XXXXXX -XX%
1-Year High: XXXXXX on 2025-05-23
1-Year Low: XX on 2025-07-06
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: X #
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: XX -XX%
1 Month: XX -XX%
1-Year High: XX on 2025-07-15
1-Year Low: X on 2025-05-13
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $dsnky in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Week: X -XX%
1 Month: XX +20%
1-Year High: XX on 2025-07-15
1-Year Low: X on 2025-05-18
The most influential creators that mention $dsnky in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Quantumup1 | X | XXXXX | X | XXXXX |
Sentiment: XXX% #
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XX%
1 Month: XXX% +50%
1-Year High: XXX% on 2025-04-30
1-Year Low: XX% on 2025-06-03
Most Supportive Themes
- IDYA Positive Outlook: (100%) RBC analysts are bullish on IDYA, citing a potential $1B revenue opportunity and a high likelihood of success for a phase III trial.
Most Critical Themes
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | X | X% |
| Total | XXXXX | XX% | XXXXX | XX% | X | X% |
Top assets mentioned In the posts about $dsnky in the last XX hours
Gilead Sciences, Inc. (GILD) WELL3 (WELL) Sarepta Therapeutics, Inc. (SRPT)
Top topics mentioned In the posts about $dsnky in the last XX hours
$gild, $zlab, manat, op, $1b, combo, $rhhby, neo, $44thinks, investment, tri, msi, $vlgea, $vcisy, $uvv, abbv, pfe, $mkkgy, $bntx, $bcax, $mrsn, glxy, $well, $srpt, $mreo, $agen, $rcus
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"TD Cowen🏁 $IDYA at a Buy rating. $PFE $GILD $DSNKY $AZN $RHHBY TD Cowen in its initiation report said "IDEAYA's pipeline with soon-to-be X clinical-stage programs represents the best of targeted oncology and is led by a world-class team. The lead daro + criz combo should launch in 2026 in mUM with a high likelihood of success in neoadjuvant. Near-term DLL3 ADC data are likely to be strong and MAT2A efficacy should add to Trodelvy with NT data. We initiate at Buy given the very attractive EV.""
@Quantumup1 on X 2025-07-22 11:42:28 UTC 3523 followers, 2384 engagements
"📈 Top Pre-Market Movers July XX 🏆 Top X Gainers: $GLXY $SBET $SBSW $KC $FORSY 🔻 Top X Losers: $SRPT $DSNKY $SKT $ZLAB $WELL Winners led by crypto & cloud names losers hit across biotech & REITs"
@overnight_stock on X 2025-07-18 08:44:34 UTC XXX followers, XXX engagements